- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about DVAX
Recent news which mentions DVAX
Valneva Shares Plunge As UK Terminates COVID-19 Vaccine Contract: What You Need Know
September 13, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 13, 2021
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
September 13, 2021
From InvestorPlace
21 Stocks Moving in Monday's Pre-Market Session
September 13, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 07, 2021
From Benzinga
The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week
September 05, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 03, 2021
From Benzinga
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
September 02, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
September 01, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
From Benzinga
From Benzinga
From Benzinga
60 Biggest Movers From Yesterday
August 24, 2021
From Benzinga
From Benzinga
Return on Capital Employed Overview: Dynavax Technologies
August 20, 2021
Tickers
DVAX
From Benzinga
Why Dynavax, Novavax, and Inovio Stocks Sank This Week
August 20, 2021
From Motley Fool
From Motley Fool
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
From Benzinga
Why Dynavax, Novavax, and Sorrento Soared This Week
August 13, 2021
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 6, 2021
August 06, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.